Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Santoni

Showing results (201-210 of 459) with videos related to

Pageof 46
Sort By:
Frontiers in Oncology|October 16, 2018
Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate CancerVincenzo Di Nunno, Lidia Gatto, Matteo Santoni, et al.
Nature Reviews. Urology|January 24, 2024
Pembrolizumab plus enfortumab vedotin in urothelial cancerMatteo Santoni, Hideki Takeshita, Francesco Massari, et al.
Anti-Cancer Drugs|August 13, 2021
A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agentsAlessandro Rizzo, Marco Oderda, Veronica Mollica, et al.
International Journal of Cancer|October 16, 2013
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trialsMatteo Santoni, Alessandro Conti, Ugo De Giorgi, et al.
Frontiers in Oncology|June 29, 2018
Exploring Small Extracellular Vesicles for Precision Medicine in Prostate CancerMatteo Giulietti, Matteo Santoni, Alessia Cimadamore, et al.
Cells|December 16, 2020
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical ApplicationsGaetano Aurilio, Alessia Cimadamore, Roberta Mazzucchelli, et al.
Immunotherapy|October 1, 2020
Designing novel immunocombinations in metastatic renal cell carcinomaMatteo Santoni, Francesco Massari, Gaetano Aurilio, et al.
Scientific Reports|November 16, 2024
Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and meta-analysisElsa Vitale, Alessandro Rizzo, Lorenza Maistrello, et al.
Cancers|December 23, 2022
Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?Javier Pozas, Sara Álvarez Rodríguez, Víctor Albarrán Fernández, et al.
Future Oncology (London, England)|May 9, 2015
Present and future of personalized medicine in adult genitourinary tumorsChiara Ciccarese, Matteo Santoni, Francesco Massari, et al.
Pageof 46

Showing results (201-210 of 459) with videos related to

Sort By:
Pageof 46
Frontiers in Oncology|October 16, 2018
Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate CancerVincenzo Di Nunno, Lidia Gatto, Matteo Santoni, et al.
Nature Reviews. Urology|January 24, 2024
Pembrolizumab plus enfortumab vedotin in urothelial cancerMatteo Santoni, Hideki Takeshita, Francesco Massari, et al.
Anti-Cancer Drugs|August 13, 2021
A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agentsAlessandro Rizzo, Marco Oderda, Veronica Mollica, et al.
International Journal of Cancer|October 16, 2013
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trialsMatteo Santoni, Alessandro Conti, Ugo De Giorgi, et al.
Frontiers in Oncology|June 29, 2018
Exploring Small Extracellular Vesicles for Precision Medicine in Prostate CancerMatteo Giulietti, Matteo Santoni, Alessia Cimadamore, et al.
Cells|December 16, 2020
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical ApplicationsGaetano Aurilio, Alessia Cimadamore, Roberta Mazzucchelli, et al.
Immunotherapy|October 1, 2020
Designing novel immunocombinations in metastatic renal cell carcinomaMatteo Santoni, Francesco Massari, Gaetano Aurilio, et al.
Scientific Reports|November 16, 2024
Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and meta-analysisElsa Vitale, Alessandro Rizzo, Lorenza Maistrello, et al.
Cancers|December 23, 2022
Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?Javier Pozas, Sara Álvarez Rodríguez, Víctor Albarrán Fernández, et al.
Future Oncology (London, England)|May 9, 2015
Present and future of personalized medicine in adult genitourinary tumorsChiara Ciccarese, Matteo Santoni, Francesco Massari, et al.
Pageof 46